Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
2.020
-0.010 (-0.49%)
At close: Jan 20, 2026, 4:00 PM EST
2.090
+0.070 (3.47%)
Pre-market: Jan 21, 2026, 4:24 AM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202013 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2013 - 2019
Genome Editing Technology
32.31M
Log In
Log In
Log In
Log In
Upgrade
Genome Editing Technology Growth
-58.64%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202013 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2013 - 2019
United States
32.31M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-58.64%
Log In
Log In
Log In
Log In
Upgrade